Beacon Therapeutics

📍 Alachua, United States🗓 Founded 2023👥 98 employees💰 Last funded Dec 2025
Biotechnology Research🌐 beacontx.com
Website LinkedIn
Beacon Therapeutics is an ophthalmic gene therapy company founded in 2023 to save and restore the vision of patients with a range of prevalent and rare retinal diseases that result in blindness. The Company has an established scientific foundation that combines a late-stage development candidate to treat X-linked retinitis pigmentosa (XLRP), as well as two preclinical programs, one targeting dry age-related macular degeneration (AMD) and another targeting cone-rod dystrophy (CRD), an inherited retinal disease. Lead development candidate AGTC-501, is a gene therapy program in Phase II clinical trials for the treatment of XLRP, an inherited monogenic recessive disorder that causes progressive vision loss in boys and young men. XLRP is predominantly caused by mutations in the retinitis pigmentosa GTPase regulator (RPGR) gene. AGTC-501 expresses the full length RPGR protein, thereby addressing the full complement of photoreceptor damage caused by XLRP, including both rod and cone loss. Beacon Therapeutics also has access to a target generation technology platform that will identify, screen, and search secreted proteins in the ophthalmology space. The Company is supported by funds from Syncona, Forbion, Oxford Science Enterprises, TCGX, Advent Life Sciences and additional investors.
4
Total investors
4
Early stage
0
Mid stage
0
Late stage
2023
Founded

Investors

4 investors
All
Early stage
Mid stage
Late stage
Investor geography4 countries
Belgium
1
United Kingdom
1
Netherlands
1
United States
1
Investor activity2023–2025 · investors recorded per year
202322024120251
Recent (last 2y)Earlier
Frequently asked questions
Who invested in Beacon Therapeutics?
Beacon Therapeutics has 4 investors on record on gritt.io, including 4 early-stage backers.
When did Beacon Therapeutics last raise funding?
The most recent investment in Beacon Therapeutics recorded on gritt.io was in December 2025.
When was Beacon Therapeutics founded?
Beacon Therapeutics was founded in 2023.
What industry is Beacon Therapeutics in?
Beacon Therapeutics operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Beacon Therapeutics based?
Beacon Therapeutics is headquartered in Alachua, United States.